A total of 1595 women with low-grade cervical cytology participating in a randomized implementation trial of HPV triaging using Hybrid Capture II were also HPV genotyped and CIN III or worse predictive values evaluated.
HPV 16 was detected in 57 % of cases with CIN III or worse but only among 24 % of all tested women. Testing for the 3 HPV types with highest risk (HPV16/31/33) detected 77 % of CIN III or worse, with 36 % of women testing positive. Positivity for the other high-risk HPV types had a decreased risk for CIN III or worse.
Different high-risk HPV types confer different risks for the presence of CIN III or worse, implying that HPV genotyping could be useful for the optimization of triaging strategies.